Myovant Sciences Ltd.
Related Filers (67)
- Sumitomo Chemical Co., Ltd. (56)
- Arjona Ferreira Juan Camilo (44)
- Sumitomo Pharma Co., Ltd. (44)
- Sumitovant Biopharma Ltd. (44)
- Lang Matthew (29)
- KARBE FRANK (22)
- Roivant Sciences Ltd. (16)
- Curran Terrie (12)
- VIKING GLOBAL INVESTORS LP (10)
- Marek David C (10)
- BB BIOTECH AG (8)
- Takeda Pharmaceuticals International AG (8)
- Dexxon Holdings Ltd. (8)
- SVF Investments (UK) Ltd (8)
- Machado Patrick (8)
- Lo Andrew (8)
- Sablich Kim (8)
- Merendino Lauren (8)
- Sebelius Kathleen (7)
- GUINAN MARK (7)
- POTTER MYRTLE S (7)
- HALVORSEN OLE ANDREAS (6)
- Ott David C. (6)
- Shabet Rose Sharon (6)
- Seely Lynn (6)
- Mehra Uneek (6)
- Gulfo Adele M. (6)
- QVT Financial LP (5)
- Altmeyer Mark (5)
- SVF GP (Jersey) Ltd (4)
- VGE III Portfolio Ltd. (4)
- Viking Global Equities II LP (4)
- SoftBank Vision Fund L.P. (4)
- Oren Dan (4)
- Viking Global Opportunities GP LLC (4)
- QVT Associates GP LLC (4)
- QVT Fund V LP (4)
- SVF Holdings (UK) LLP (4)
- Viking Global Opportunities Illiquid Investments Sub-Master LP (4)
- Dexcel Pharma Technologies Ltd. (4)
- VIKING GLOBAL PERFORMANCE LLC (4)
- Viking Long Fund GP LLC (4)
- Viking Global Equities LP (4)
- Viking Global Opportunities Portfolio GP LLC (4)
- Viking Long Fund Master Ltd. (4)
- JANUS HENDERSON GROUP PLC (4)
- Valente Nancy (4)
- DeVeydt Wayne S (3)
- TAKEDA PHARMACEUTICAL CO LTD (3)
- Viking Global Equities Master Ltd. (3)
- Torti Frank (3)
- MILLENNIUM PHARMACEUTICALS INC (2)
- RA CAPITAL MANAGEMENT, L.P. (2)
- WELLINGTON MANAGEMENT GROUP LLP (2)
- Romeo Marianne L. (1)
- Ramaswamy Vivek (1)
- Sundheim Daniel S. (1)
- MANCHESTER KEITH S (1)
- Takeda A/S (1)
- Takeda Europe Holdings B.V. (1)
- Takeda Pharma A/S (1)
- Takeda Pharmaceuticals U.S.A., Inc. (1)
- Nomura Hiroshi (1)
- Nishinaka Shigeyuki (1)
- FIL Ltd (1)
- Alpine Global Management, LLC (1)
- NEW YORK STOCK EXCHANGE LLC (1)
- Show More ...
Financials (27)
10-Q
Thursday, 1/26/2023
Quarterly Report for period ending 2022-12-31
10-Q
Wednesday, 10/26/2022
Quarterly Report for period ending 2022-09-30
10-Q
Wednesday, 7/27/2022
Quarterly Report for period ending 2022-06-30
10-K
Wednesday, 5/11/2022
Annual Report for period ending 2022-03-31
10-Q
Wednesday, 1/26/2022
Quarterly Report for period ending 2021-12-31
10-Q
Tuesday, 10/26/2021
Quarterly Report for period ending 2021-09-30
10-Q
Wednesday, 7/28/2021
Quarterly Report for period ending 2021-06-30
10-K
Tuesday, 5/11/2021
Annual Report for period ending 2021-03-31
10-Q
Thursday, 2/11/2021
Quarterly Report for period ending 2020-12-31
10-Q
Thursday, 11/12/2020
Quarterly Report for period ending 2020-09-30
10-Q
Tuesday, 8/11/2020
Quarterly Report for period ending 2020-06-30
10-K
Monday, 5/18/2020
Annual Report for period ending 2020-03-31
10-Q
Monday, 2/10/2020
Quarterly Report for period ending 2019-12-31
10-Q
Tuesday, 11/12/2019
Quarterly Report for period ending 2019-09-30
10-Q
Tuesday, 8/6/2019
Quarterly Report for period ending 2019-06-30
10-K
Friday, 5/24/2019
Annual Report for period ending 2019-03-31
10-Q
Thursday, 2/7/2019
Quarterly Report for period ending 2018-12-31
10-Q
Thursday, 11/8/2018
Quarterly Report for period ending 2018-09-30
10-Q/A
Monday, 9/17/2018
Quarterly Report for period ending 2018-06-30
10-Q
Tuesday, 8/7/2018
Quarterly Report for period ending 2018-06-30
10-K
Thursday, 6/7/2018
Annual Report for period ending 2018-03-31
10-Q
Tuesday, 2/13/2018
Quarterly Report for period ending 2017-12-31
10-Q
Monday, 11/13/2017
Quarterly Report for period ending 2017-09-30
10-Q
Thursday, 8/10/2017
Quarterly Report for period ending 2017-06-30
10-K
Wednesday, 6/14/2017
Annual Report for period ending 2017-03-31
10-Q
Monday, 2/13/2017
Quarterly Report for period ending 2016-12-31
10-Q
Friday, 12/9/2016
Quarterly Report for period ending 2016-09-30
News (66)
8-K
Friday, 3/10/2023
Current report filing
8-K
Wednesday, 3/1/2023
Current report filing
8-K
Thursday, 1/26/2023
Current report filing
8-K
Wednesday, 10/26/2022
Current report filing
8-K
Monday, 10/24/2022
Current report filing
8-K
Friday, 10/21/2022
Current report filing
8-K
Monday, 10/3/2022
Current report filing
8-K
Wednesday, 7/27/2022
Current report filing
8-K
Tuesday, 5/10/2022
Current report filing
8-K
Friday, 3/25/2022
Current report filing
8-K
Wednesday, 1/26/2022
Current report filing
8-K
Monday, 1/10/2022
Current report filing
8-K
Monday, 11/8/2021
Current report filing
8-K
Tuesday, 10/26/2021
Current report filing
8-K
Thursday, 8/12/2021
Current report filing
8-K
Wednesday, 7/28/2021
Current report filing
8-K
Wednesday, 7/7/2021
Current report filing
8-K
Friday, 6/4/2021
Current report filing
8-K
Wednesday, 5/26/2021
Current report filing
8-K
Wednesday, 5/19/2021
Current report filing
8-K
Tuesday, 5/11/2021
Current report filing
8-K
Thursday, 2/11/2021
Current report filing
8-K
Monday, 1/4/2021
Current report filing
8-K
Monday, 12/28/2020
Current report filing
8-K
Friday, 12/18/2020
Current report filing
8-K
Thursday, 11/12/2020
Current report filing
8-K
Thursday, 9/17/2020
Current report filing
8-K
Tuesday, 8/11/2020
Current report filing
8-K
Wednesday, 8/5/2020
Current report filing
8-K
Monday, 5/18/2020
Current report filing
8-K
Friday, 5/8/2020
Current report filing
8-K
Monday, 2/10/2020
Current report filing
8-K
Monday, 12/30/2019
Current report filing
8-K
Tuesday, 11/12/2019
Current report filing
8-K
Thursday, 10/31/2019
Current report filing
8-K
Tuesday, 8/27/2019
Current report filing
8-K
Tuesday, 8/6/2019
Current report filing
8-K
Tuesday, 6/4/2019
Current report filing
8-K
Friday, 5/31/2019
Current report filing
8-K
Friday, 5/24/2019
Current report filing
8-K
Tuesday, 5/14/2019
Current report filing
8-K
Thursday, 2/7/2019
Current report filing
8-K
Monday, 12/31/2018
Current report filing
8-K
Thursday, 11/8/2018
Current report filing
8-K
Monday, 9/24/2018
Current report filing
8-K
Tuesday, 9/4/2018
Current report filing
8-K
Tuesday, 8/7/2018
Current report filing
8-K
Tuesday, 7/24/2018
Current report filing
8-K
Friday, 7/13/2018
Current report filing
8-K
Tuesday, 7/10/2018
Current report filing
8-K
Thursday, 6/7/2018
Current report filing
8-K
Tuesday, 6/5/2018
Current report filing
8-K
Wednesday, 4/4/2018
Current report filing
8-K
Tuesday, 4/3/2018
Current report filing
8-K
Friday, 3/30/2018
Current report filing
8-K
Thursday, 3/22/2018
Current report filing
8-K
Tuesday, 2/13/2018
Current report filing
8-K
Friday, 2/9/2018
Current report filing
8-K
Monday, 11/13/2017
Current report filing
8-K
Monday, 10/16/2017
Current report filing
8-K
Wednesday, 8/23/2017
Current report filing
8-K
Thursday, 8/10/2017
Current report filing
8-K/A
Thursday, 4/27/2017
Current report filing
8-K
Monday, 4/3/2017
Current report filing
8-K
Thursday, 11/17/2016
Current report filing
8-K
Thursday, 11/3/2016
Current report filing
Other (26)
15-12G
Monday, 3/20/2023
Notice of termination of registration of a class of securities under Section 12(g)
EFFECT
Thursday, 3/16/2023
Notice of Effectiveness
EFFECT
Thursday, 3/16/2023
Notice of Effectiveness
POS AM
Friday, 3/10/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Friday, 3/10/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
25-NSE
Friday, 3/10/2023
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
CT ORDER
Monday, 2/6/2023
Order Granting Confidential Treatment
CORRESP
Friday, 1/6/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Tuesday, 7/27/2021
Order Granting Confidential Treatment
SEC STAFF LETTER
Friday, 3/26/2021
None
SEC STAFF LETTER
Friday, 2/26/2021
None
EFFECT
Thursday, 8/6/2020
Notice of Effectiveness
POS AM
Tuesday, 5/19/2020
Post-effective amendment to a registration statement that is not immediately effective upon filing
POSASR
Friday, 5/15/2020
Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
CT ORDER
Monday, 10/1/2018
Order Granting Confidential Treatment
EFFECT
Friday, 3/23/2018
Notice of Effectiveness
CORRESP
Wednesday, 3/21/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Thursday, 10/27/2016
Order Granting Confidential Treatment
EFFECT
Wednesday, 10/26/2016
Notice of Effectiveness
8-A12B
Monday, 10/24/2016
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CERTNYS
Monday, 10/24/2016
None
CERTNYS
Monday, 10/24/2016
None
CORRESP
Monday, 10/24/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 10/24/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 10/12/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/7/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Ownership (357)
4
Friday, 3/10/2023
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
Mehra Uneek: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
Gulfo Adele M.: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
Valente Nancy: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
Sumitomo Pharma Co., Ltd.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 3/10/2023
Sumitomo Chemical Co., Ltd.: Major Shareholders
4
Friday, 3/10/2023
Marek David C: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
POTTER MYRTLE S: Statement of changes in beneficial ownership of securities
SC 13E3/A
Friday, 3/10/2023
Schedule filed to report going private transactions
4
Friday, 3/10/2023
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
GUINAN MARK: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
Merendino Lauren: Statement of changes in beneficial ownership of securities
4
Monday, 3/6/2023
Sumitomo Pharma Co., Ltd.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 3/6/2023
Sumitomo Chemical Co., Ltd.: Major Shareholders
SC 13G
Friday, 2/17/2023
Alpine Global Management, LLC: Major Shareholders
SC 13E3/A
Thursday, 2/16/2023
Schedule filed to report going private transactions
SC 13G/A
Tuesday, 2/14/2023
BB BIOTECH AG: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
JANUS HENDERSON GROUP PLC: Major Shareholders
SC 13G
Thursday, 2/9/2023
FIL Ltd: Major Shareholders
SC 13G/A
Monday, 2/6/2023
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13E3/A
Monday, 1/23/2023
Schedule filed to report going private transactions
4
Friday, 1/20/2023
Marek David C: Statement of changes in beneficial ownership of securities
4
Friday, 1/20/2023
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Friday, 1/20/2023
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Friday, 1/20/2023
Merendino Lauren: Statement of changes in beneficial ownership of securities
SC 13E3/A
Friday, 1/6/2023
Schedule filed to report going private transactions
4
Thursday, 1/5/2023
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2022
Mehra Uneek: Statement of changes in beneficial ownership of securities
SC 13E3
Friday, 12/9/2022
Schedule filed to report going private transactions
4
Friday, 10/28/2022
GUINAN MARK: Statement of changes in beneficial ownership of securities
4
Friday, 10/28/2022
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Friday, 10/28/2022
POTTER MYRTLE S: Statement of changes in beneficial ownership of securities
4
Friday, 10/28/2022
Valente Nancy: Statement of changes in beneficial ownership of securities
4
Friday, 10/28/2022
Gulfo Adele M.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 10/24/2022
Sumitomo Chemical Co., Ltd.: Major Shareholders
3
Friday, 10/21/2022
Nishinaka Shigeyuki: Initial statement of beneficial ownership of securities
4
Thursday, 10/20/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Thursday, 10/20/2022
Marek David C: Statement of changes in beneficial ownership of securities
4
Thursday, 10/20/2022
Merendino Lauren: Statement of changes in beneficial ownership of securities
4
Thursday, 10/20/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Thursday, 10/6/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Thursday, 10/6/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 10/3/2022
Sumitomo Chemical Co., Ltd.: Major Shareholders
4
Tuesday, 9/20/2022
Mehra Uneek: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/16/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/20/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/20/2022
Marek David C: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/20/2022
Merendino Lauren: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/20/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Friday, 7/8/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Friday, 7/8/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2022
Marek David C: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2022
Merendino Lauren: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/19/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/19/2022
Mehra Uneek: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/19/2022
Marek David C: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/19/2022
Merendino Lauren: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/19/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Thursday, 4/7/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Thursday, 4/7/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/11/2022
BB BIOTECH AG: Major Shareholders
SC 13G/A
Thursday, 2/10/2022
JANUS HENDERSON GROUP PLC: Major Shareholders
SC 13G
Friday, 2/4/2022
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
4
Friday, 1/21/2022
Marek David C: Statement of changes in beneficial ownership of securities
4
Thursday, 1/6/2022
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Thursday, 1/6/2022
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/1/2021
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/9/2021
POTTER MYRTLE S: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/9/2021
Valente Nancy: Initial statement of beneficial ownership of securities
4
Tuesday, 11/9/2021
GUINAN MARK: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/9/2021
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/9/2021
Gulfo Adele M.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/9/2021
Valente Nancy: Statement of changes in beneficial ownership of securities
4
Friday, 11/5/2021
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 10/27/2021
Sumitomo Chemical Co., Ltd.: Major Shareholders
4
Thursday, 10/7/2021
Lang Matthew: Statement of changes in beneficial ownership of securities
4
Thursday, 10/7/2021
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Thursday, 9/30/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/29/2021
Arjona Ferreira Juan Camilo: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/28/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/22/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Friday, 9/17/2021
Mehra Uneek: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 9/17/2021
Sumitomo Chemical Co., Ltd.: Major Shareholders
4
Thursday, 9/16/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/14/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Monday, 9/13/2021
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Friday, 9/10/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
3
Thursday, 9/9/2021
Mehra Uneek: Initial statement of beneficial ownership of securities
4
Wednesday, 9/8/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Friday, 9/3/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
4
Friday, 9/3/2021
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/1/2021
Dainippon Sumitomo Pharma Co Ltd: Statement of changes in beneficial ownership of securities
Prospectus (37)
S-8 POS
Friday, 3/10/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Friday, 3/10/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Friday, 3/10/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Friday, 3/10/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Friday, 3/10/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Friday, 3/10/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Friday, 3/10/2023
Post-effective amendment to a S-8 registration statement
S-8
Friday, 4/8/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Tuesday, 4/6/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 11/12/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 5/18/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Tuesday, 8/6/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 5/31/2019
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 5/29/2019
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Friday, 5/24/2019
Automatic shelf registration statement of securities of well-known seasoned issuers
S-8
Thursday, 11/8/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 7/13/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 7/11/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 4/3/2018
Prospectus filed pursuant to Rule 424(b)(5)
S-3/A
Friday, 3/23/2018
Registration statement for specified transactions by certain issuers
S-3/A
Friday, 12/15/2017
Registration statement for specified transactions by certain issuers
S-3
Monday, 11/13/2017
Registration statement for specified transactions by certain issuers
S-8
Wednesday, 5/17/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Thursday, 10/27/2016
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Wednesday, 10/26/2016
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Tuesday, 10/25/2016
General form of registration statement for all companies including face-amount certificate companies
FWP
Monday, 10/24/2016
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Monday, 10/24/2016
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Thursday, 10/20/2016
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 10/17/2016
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 10/12/2016
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 9/30/2016
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Friday, 9/23/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 9/23/2016
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 8/26/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Thursday, 8/25/2016
Correspondence Related to Draft Registration Statement
DRS
Monday, 7/11/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (22)
DEFA14A
Thursday, 2/16/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 2/2/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFM14A
Monday, 1/23/2023
Definitive proxy statement relating to a merger, acquisition, or disposition
PRER14A
Friday, 1/6/2023
Preliminary revised proxy soliciting materials
PREM14A
Thursday, 12/8/2022
Preliminary proxy statement relating to a merger, acquisition, or disposition
DEFA14A
Tuesday, 10/25/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Monday, 10/24/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 7/28/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 7/28/2022
Definitive proxy statements
DEFA14A
Wednesday, 7/28/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 7/28/2021
Definitive proxy statements
DEFA14A
Friday, 7/24/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 7/24/2020
Definitive proxy statements
DEF 14C
Friday, 1/3/2020
Definitive information statements
PRE 14C
Monday, 12/23/2019
Preliminary information statement not related to a contested matter or merger/acquisition
DEF 14A
Thursday, 7/25/2019
Definitive proxy statements
DEF 14C
Tuesday, 6/4/2019
Definitive information statements
PRE 14C
Friday, 5/24/2019
Preliminary information statement not related to a contested matter or merger/acquisition
DEF 14A
Wednesday, 7/25/2018
Definitive proxy statements
DEF 14A
Monday, 1/22/2018
Definitive proxy statements
PRE 14A
Tuesday, 1/9/2018
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Friday, 7/21/2017
Definitive proxy statements